Clinical Trials Browser

Observational × daratumumab × 90 days × Clear all

NCT06549634 2026-02-27

Biomarkers of AKI in Patients Receiving Daratumumab

GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury